After More Than 60 Years, Scientists Discover a Stunning New Twist in How a Common Diabetes Drug Actually Works
For decades, attention in diabetes treatment has shifted toward flashy newcomers like Ozempic and Mounjaro. These drugs dominate headlines for their impressive blood-sugar and weight-loss results. But what if one of the oldest diabetes medications—metformin—has been hiding a surprising secret all along? After 60 years of use, researchers have just uncovered that this trusted pill does something remarkable inside the brain. And this is the part most people never expected...
A groundbreaking study published in Science Advances has revealed that metformin may regulate blood sugar not just through the liver, as long believed, but also through specific pathways in the brain. Traditionally, experts thought metformin primarily lowered glucose by suppressing the liver’s production of sugar. However, this new research suggests a major portion of metformin’s action might actually be happening in the brain itself.
What the New Study Found
The team behind the discovery—led by Christoph Buettner, M.D., Ph.D., from Rutgers Robert Wood Johnson Medical School—identified how metformin interacts with a key brain region called the ventromedial hypothalamus. In earlier experiments with mice, the same scientists discovered a brain protein named Rap1 that influences how the body processes glucose. When metformin reached that brain region, it effectively switched Rap1 off.
To test this further, the researchers bred mice that completely lacked Rap1. Surprisingly, metformin stopped working for blood sugar control in these mice, even though other diabetes medications still did. The conclusion? The brain—and not just the liver—plays a central role in how metformin works.
This finding could change how scientists think about diabetes treatment forever. But it also raises a bold question: if metformin’s real power begins in the brain, what else might this humble drug be capable of?
What Is Metformin, Anyway?
Metformin belongs to a class of medications known as biguanides and is one of the most widely prescribed treatments for type 2 diabetes. According to the U.S. National Library of Medicine, it helps control blood sugar by reducing how much sugar the body absorbs from food and by limiting glucose production in the liver. At the same time, it heightens the body’s sensitivity to insulin—the hormone responsible for keeping glucose levels in check.
Jamie K. Alan, Ph.D., an associate professor of pharmacology and toxicology at Michigan State University, explains that although metformin has long been studied for diabetes, researchers are also exploring its potential use against cancer, polycystic ovary syndrome (PCOS), and even aging-related conditions. “Metformin has been around for more than six decades, but new findings are constantly reshaping how we understand its full scope,” Alan says.
And here’s where it gets even more intriguing: because metformin can cross the blood–brain barrier, scientists are beginning to evaluate whether it could help with mental health conditions like depression or neurological diseases. Kelly Johnson-Arbor, M.D., a toxicologist at MedStar Health, notes, “This opens the door to studying metformin as a potential brain-targeted therapy, not just a metabolic one.”
Why This Discovery Matters
The revelation about metformin’s effect on the brain does more than fill a missing piece of a scientific puzzle—it could change how doctors approach treatment. Despite being the single most prescribed diabetes medication worldwide, metformin’s precise mechanism has stayed partly mysterious. “It’s astonishing that after all this time, we’re still learning how it works,” says Dr. Buettner.
The implications go far beyond diabetes, too. Understanding how the brain controls blood sugar could explain why some people taking metformin report reduced appetite, slight weight loss, and even improvements in mental clarity—effects typically linked to brain function. Dr. Alan emphasizes that studying the brain’s role could eventually lead to new strategies for managing appetite and satiety. “We still have so much to discover about how the brain regulates hunger and blood sugar,” she says.
There’s also a social and practical twist to this story. Unlike newer drugs such as Ozempic and Mounjaro, which require costly injections, metformin is taken orally and remains one of the most affordable diabetes treatments available. “It’s accessible, effective, and inexpensive,” Alan notes. “Figuring out new ways to use metformin—or drugs like it—would be a massive victory for patients and the medical community alike.”
What Comes Next
Of course, these findings are only the beginning. The researchers behind this study have already announced plans to expand their work, exploring how metformin’s brain effects show up in human studies. Still, experts caution that translating these discoveries into clinical use will take time.
“This is early-stage research,” Alan says. “It’s far from being applied to patient care, but it’s an important step forward.”
The potential future is exciting: if metformin’s influence on the brain can be fully mapped, it might inspire better treatments not only for diabetes, but also for neurological disorders, mood issues, and even heart disease.
So here’s the thought-provoking part: could one of medicine’s oldest—and cheapest—drugs hold the key to understanding both metabolic and mental health? Or are scientists reading too much into an old molecule’s familiar story? The debate is just beginning—what’s your take on it?
